5 federal workers sue Trump admin over OPM trans care ban, citing Title VII

For the legal community, this case is a pivotal test of whether Title VII’s prohibition on sex discrimination extends to employer-sponsored health plans that exclude transition-related care. The plaintiffs are leveraging the Supreme Court’s Bostock reasoning to argue that the OPM ban facially discriminates on the basis of sex. The litigation’s trajectory—from D.C. District Court to likely appellate review—will offer a real-time tutorial on the application of anti-discrimination statutes to benefit design, with potential ripple effects for all employers.

On August 3, 2026, five federal employees, represented by the Human Rights Campaign Foundation, filed a class-action lawsuit in the U.S. District Court for the District of Columbia. The suit challenges the Trump administration’s Office of Personnel Management (OPM) ban on coverage for transgender chemical and surgical procedures under the Federal Employees Health Benefits (FEHB) program. The ban, announced at the start of 2026, marks a dramatic reversal of coverage that had been standard across many FEHB plans, directly affecting thousands of federal workers and their dependents. The plaintiffs, who are seeking treatment for themselves or a family member, describe severe financial consequences: they are unable to pay out-of-pocket for procedures, are draining savings, or are incurring significant debt to meet medical needs. This case arrives amid a broader landscape of Trump administration efforts to restrict transgender rights, including halting medical interventions for transgender inmates, cutting federal grants to programs supporting gender-affirming care, and reinstating a ban on transgender troops.

“

The suit challenges the Trump administration’s Office of Personnel Management (OPM) ban on coverage for transgender chemical and surgical procedures under the Federal Employees Health Benefits (FEHB) program.

At the heart of the lawsuit is Title VII of the Civil Rights Act of 1964, which prohibits employment discrimination “because of… sex.” The plaintiffs argue that denying insurance coverage for gender-affirming procedures, while covering similar procedures for non-transgender individuals, constitutes sex discrimination. This argument draws heavily on the Supreme Court’s 2020 decision in Bostock v. Clayton County, which held that discrimination against an individual for being transgender is a form of sex discrimination. However, the legal landscape is far from settled. Last year—2025—the Supreme Court upheld state restrictions on transgender procedures for minors, but that case did not address adult coverage in an employment context. The administration is likely to argue that OPM’s action is a policy choice about the scope of benefits, not discrimination, and that Bostock does not compel coverage of particular medical services.